INTRODUCTION

77
HLA molecules affect susceptibility to many diseases, but in the majority of cases the mechanism by 78 which HLA molecules predispose to disease remains a mystery. The risks of developing both ankylosing 79 spondylitis (AS) and rheumatoid arthritis are primarily driven by genetic effects, with heritability >90%
80
(1, 2) for AS, and 53-68% for RA (3, 4). In both diseases HLA alleles are the major susceptibility factors,
81
with AS being strongly associated with HLA-B27, and RA with HLA-DRB1 'shared-epitope' (SE) alleles.
83
Particularly in AS, there is strong evidence of a role for gut disease in disease pathogenesis. Up to an 
94
Using 16S rRNA community profiling we have previously demonstrated that AS cases have a discrete 95 intestinal microbial signature in the terminal ileum (TI) compared with healthy controls (HC) (P<0.001)
96
(20), a finding that has subsequently been confirmed by other studies (21, 22) . We have also 97 demonstrated that dysbiosis is an early feature of disease in HLA-B27 transgenic rats, preceding the 98 onset of clinical disease in the gut or joints (23). Similarly, RA cases have also been shown to have gut 99 dysbiosis (24, 25), and animal models of RA such as collagen-induced arthritis have been shown to be 100 influenced by the gut microbiome (26, 27) . In these studies it is difficult to distinguish between effects 101 of the immunological processes going on in the intestinal wall in cases, and the effects of treatments 102 on the intestinal microbiome, from potential effects of the gut microbiome on the disease. 
104
112
Further studies are needed into whether the changes in intestinal microbial composition are due to 113 host genetics, and how this affects the overall function of the gut microbiome in cases, including how 114 the microbiome then goes on to shape the immune response and influence inflammation. In AS, given 115 the strong association of HLA-B27, the hypothesis has been raised that HLA-B27 induces AS by effects 
124
In this study we investigated if AS and RA-associated HLA alleles influence the gut microbiome in 125 healthy individuals, to support the hypothesis that they influence the risk of developing AS and RA 126 through effects on the gut microbiome.
127
METHODS
128
Human subjects 
129
136
to collect a stool sample on a sterile swab at home, just prior to starting their bowel prep procedure.
137
Stool samples were brought to the colonoscopy appointment at room temperature. All samples
138
(biopsies and fecal swabs) were placed at 4°C in the clinic and transported to the lab within 2 hours of 139 the colonoscopy procedure, where they were snap frozen and stored at -80°C prior to processing. 
186
RESULTS
187
16S rRNA profiling and SNP array genotyping was successfully completed for 107 individuals (61 188 female, 46 male) involving a total of 564 biopsy samples (see Table 1 ).
190
We studied the effect of BMI, gender and sampling site on the gut microbiome to identify relevant 191 covariates for analysis of AS-associated genes and their association with the gut microbiome.
192
Considering sample site, striking differences were observed, particularly between the stool samples 
198
Stool samples are much more convenient to obtain than ileal or colonic mucosal samples, which 199 require an endoscopic procedure for collection. Given the prior evidence of primarily ileal 200 inflammation in AS (5), we were interested in the relationship between the ileal and stool microbiome.
201
In this comparison marked differences were observed between sites, though with some overlap seen 
240 241
Considering beta diversity via sPLSDA and PERMANOVA, significant association of BMI category was 242 seen with microbiome composition (P=0.0022)(Supplementary Figure 3A) . This appears to be driven 
247
Given the marked gender biases in RA and AS, and evidence in mice that gender related hormonal 
276
We tested whether HLA-B alleles associated with AS were also associated with gut microbial profiles.
277
The association of HLA-B alleles with AS is complex, with risk associations observed with HLA-B27, -
278
B13, -B40, -B47 and -B51, and protective associations with HLA-B7 and -B57 (55). Of these, only HLA-
279
B27 showed statistically significant association with microbiome profile across both cohorts.
280
Differences in the microbiome composition were more pronounced when comparing risk-associated 
352
Of these we also see reduction in Blautia obeum. Although we did not find dysbiotic changes that were
353
shared with these specific taxa, we note the enrichment of genera within the Lachospiraceae-
354
Ruminococcaceae grouping in HLA-B27 carriers was a shared feature of our studies; Roseburia and
355
Ruminococcus by Breban et al (22) and Roseburia, Blautia, Dorea and Oscillospira in our current study.
356
These bacteria are known to be enriched within the intestinal mucosa (59), and are plausibly more
357
immunogenic as a result (60). The differences observed between these studies may relate to analytical 
369
Another possibility is that differences in microbial gene content, not necessarily specific taxa, may be 370 more significant. In the current study, the microbiome's predicted gene content was extrapolated
371
from the underlying taxonomy, therefore utilization of whole genome sequencing metagenomics
372
(a.k.a. shotgun metagenomics) to directly profile genetic composition may prove fruitful. This will be 373 the focus of subsequent studies.
375
HLA molecules affect susceptibility to many diseases, most of which are immunologically mediated. In 376 almost all instances, the mechanism that accounts for that predisposition is not known. The 
384
The hypothesized metabolic changes imbued by dysbiosis in our current work are of interest in light 385 of a recent study by our group in the HLA-B27 transgenic rat model of spondyloarthritis (66 
